SCHEMBL14128808

SCHEMBL14128808

CCN1CCC(OC(=O)C(c2ccccc2)c2ccccc2)C1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 4/20 0.86
CYP3A4 P08684 3/20 0.86
CYP1A2 P05177 3/20 0.86
TP53 P04637 1/20 0.65
PKM P14618 1/20 0.65
NFKB1 P19838 1/20 0.65
THPO P40225 1/20 0.65
HIF1A Q16665 1/20 0.65
LMNA P02545 3/20 0.64
THRB P10828 3/20 0.64
BLM P54132 3/20 0.64
PMP22 Q01453 3/20 0.64
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
GMNN O75496 1/20 0.64
ALDH1A1 P00352 1/20 0.64
MAPT P10636 1/20 0.64
HTT P42858 1/20 0.63
CHRM2 P08172 5/20 0.54
CHRM4 P08173 5/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14125434 1.00 CYP2D6 (0.86) CYP2D6CYP3A4CYP1A2TP53PKM
Piperidolate SCHEMBL249131 0.92 CYP2D6 (1.00) CYP2D6CYP3A4CYP1A2TP53PKM
Piperidolate SCHEMBL28832658 0.92 CYP2D6 (1.00) CYP2D6CYP3A4CYP1A2TP53PKM
Piperidolate SCHEMBL2734595 0.91 CYP2D6 (0.98) CYP2D6CYP3A4CYP1A2TP53PKM
Piperidolate SCHEMBL437741 0.91 CYP3A4 (1.00) CYP2D6CYP3A4CYP1A2TP53PKM
Piperidolate SCHEMBL1649482 0.90 CYP2D6 (0.95) CYP2D6CYP3A4CYP1A2TP53PKM
SCHEMBL9667144 0.80 CYP2D6 (0.74) CYP2D6CYP3A4CYP1A2TP53PKM
SCHEMBL343231 0.79 CYP2D6 (0.71) CYP2D6CYP3A4CYP1A2TP53PKM
SCHEMBL7649270 0.79 CYP2D6 (0.77) CYP2D6CYP3A4CYP1A2TP53PKM
Bromide SCHEMBL9667278 0.79 CYP2D6 (0.73) CYP2D6CYP3A4CYP1A2TP53PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012166909-A1 COMPOSITIONS AND METHODS FOR TREATING BREATHING CONTROL DISORDERS OR DISEASES GALLEON PHARMACEUTICALS, INC. (US) 2012-12-06 WO disclosed